Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-12-20

Clinical Trial Update: Apneic Oxygenation Via Nasal Cannulae Prevents Arterial Hypoxemia [NA]

View source ↗

Summary

A clinical trial update shows that apneic oxygenation using nasal cannulae can prevent arterial hypoxemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Manitoba | Conditions: Hypoxia | NA | Status: COMPLETED